Leah Strickling
About Leah Strickling
Leah Strickling serves as the Associate Director of Corporate Development and Strategy at Nimbus Therapeutics, where she has worked since 2023. She has a background in corporate strategy and consulting within the life sciences sector, having held positions at Back Bay Life Science Advisors and Valo, among others.
Current Role at Nimbus Therapeutics
Leah Strickling serves as the Associate Director of Corporate Development and Strategy at Nimbus Therapeutics. She has held this position since 2023, contributing to the company's strategic initiatives and corporate development efforts. Nimbus Therapeutics is known for its innovative approaches in drug discovery and development, particularly in the fields of oncology and immunology.
Previous Experience at Valo
Prior to her current role, Leah Strickling worked at Valo from 2021 to 2023. She began as a Senior Manager in Corporate Strategy and later advanced to Associate Director of Corporate Strategy. During her tenure, she focused on strategic planning and execution, playing a key role in shaping the company's corporate direction.
Experience at Back Bay Life Science Advisors
Leah Strickling has extensive experience with Back Bay Life Science Advisors, where she worked in various capacities from 2017 to 2021. She started as an Analyst and progressed to Senior Consultant. Her work involved providing strategic consulting services to clients in the life sciences sector, emphasizing market analysis and business development strategies.
Educational Background in Pharmacology
Leah Strickling earned her Bachelor of Science (B.Sc.) degree in Pharmacology from McGill University, where she studied from 2012 to 2016. Her education provided her with a strong foundation in the biological sciences, which supports her work in corporate strategy within the life sciences industry.
Early Career at Merck Group
Leah Strickling began her career at Merck Group, where she held two positions in 2016 and 2017. She worked as an Associate in Global Medical Affairs for Oncology and later in Global Business Franchise for Neurology and Immunology. These roles allowed her to gain valuable insights into the pharmaceutical industry and develop expertise in medical affairs.